REFRACTORY PROSTATE CARCINOMA

Clinical trials for REFRACTORY PROSTATE CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY PROSTATE CARCINOMA trials appear

Sign up with your email to follow new studies for REFRACTORY PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for men with Tough-to-Treat prostate cancer

Disease control Ongoing

This study is testing an experimental pill called M1774 for men with advanced prostate cancer that has a specific genetic change (SPOP mutation) and has stopped responding to standard treatments. The pill aims to block a protein that cancer cells need to grow, potentially shrinki…

Matched conditions: REFRACTORY PROSTATE CARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 20:26 UTC

REFRACTORY PROSTATE CARCINOMA

Get alerted when new REFRACTORY PROSTATE CARCINOMA trials appear

New hope for men with Tough-to-Treat prostate cancer